RootsAnalysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB,MSI / MMR and TILs Testing, 2019–2030.”
The report features an extensive study of the currentlandscape and future outlook of the immuno-oncology biomarkers testing market(focusing particularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)). Itprovides an in-depth analysis, highlighting the capabilities of the variouscompanies engaged in this domain. Amongst various elements, the reportincludes:
· A detailed analysis of ongoing,biomarker-based clinical trials initiated by big pharmaceutical companies.
· An analysis of the landscape of companiesoffering testing services for cancer biomarkers, namely TMB, MSI / MMR and TILs(including CD3+, CD4+, CD8+ and FOXP3+).
· An insightful 2X2 representation of theresults of a detailed competitiveness analysis of various tests (segregatedacross different biomarker groups).
· Elaborate profiles of leading analyticaltesting service providers focused on immuno-oncology biomarkers (shortlistedbased on strength of service portfolio).
· A detailed publication analysis of over 180research articles that have been published since 2016, highlighting the keyfocus areas of ongoing research activity related to immuno-oncology biomarkers,namely TMB, MSI / MMR and TILs.
· A comprehensive clinical trial analysis ofcompleted, ongoing and planned studies, focused on the assessment of cancerbiomarkers, namely TMB, MSI / MMR and TILs.
· A discussion on the upcoming opportunitiesthat are likely to impact the evolution of this market over the coming years.
· A discussion on various steps involved indevelopment operations of companion diagnostics
· A comparative analysis of the needs ofdifferent stakeholders involved in the development of companion diagnosticproducts.
Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)
Requestfor Customization:
https://www.rootsanalysis.com/reports/253/request-customization.html
Typeof test
· Laboratory Developed Tests (LDTs)
· Companion Diagnostic Tests (CDx)
Typeof disease indication
· Breast cancer
· Blood cancer
· Colon / Colorectal cancer
· Lung Cancer
· Melanoma
· Prostate Cancer
Typeof cancer biomarker
· TMB
· MSI / MMR
· TILs
Typeof analytical technique
· Next Generation Sequencing (NGS)
· Polymerase Chain Reaction (PCR)
· Immunohistochemistry (IHC)
· Others
Keygeographical regions
· North America
· Europe
· Japan
· China
· Australia
Keycompanies covered in the report
· Foundation Medicine
· NeoGenomics Laboratories
· Novogene
· Q2 Solutions
· Personal Genome Diagnostics
· Dr Lal PathLabs
· Shenzhen Yuce Biotechnology
Enquirybefore Purchasing:
https://www.rootsanalysis.com/reports/253/request-sample.html
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights are drivenby an experienced leadership team which has gained many years of significantexperience in this sector. If you’d like help with your growing business needs,get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
PleaseVisit Our Upcoming Reports
Gonorrhea:Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031
LactoseIntolerance: Pipeline Review, Developer Landscape and Competitive Insights,2021-2031
ColdChain Logistics Market, Industry Trends and Global Forecasts, 2021-2030
